We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Catheter Directed Therapy for Pulmonary Embolism Proves Successful

By HospiMedica International staff writers
Posted on 24 Nov 2009
A new study claims that-catheter-directed thrombolysis (CDT) should be considered a first-line treatment option for massive blood clots in the lungs.

Researchers at Stanford University Medical Center (CA, USA) conducted a systematic review of electronic literature searches (MEDLINE, EMBASE) for studies published from January 1990 through September 2008. More...
Inclusion criteria were applied to select patients with acute massive pulmonary embolism (PE) treated with modern CDT. Paired reviewers assessed study quality and abstracted data; clinical success was defined as stabilization of hemodynamics, resolution of hypoxia, and survival to hospital discharge.

The researchers found that in 594 patients from 35 studies (6 prospective, 29 retrospective) that met the criteria for inclusion, the pooled clinical success rate from CDT was 86.5%. The pooled risks of minor and major procedural complications were 7.9% and 2.4%, respectively. The researchers also found that not only was the treatment effective, but it also appeared much safer than the historical complication rates reported from injecting high-dose clot-busting medicine systemically or directly into the blood stream, where the drug can circulate throughout the body and cause major bleeding in up to 20% of patients. The study was published in the November 2009 issue of the Journal of Vascular and Interventional Radiology.

"Modern catheter-directed therapy for acute pulmonary embolism saves lives, and we need to raise awareness about its safety and effectiveness not only among the general public but also within the medical community. It's a matter of life and death,” said lead author William Kuo, M.D., of the department of radiology at Stanford. "In our study, we conclude that modern catheter-directed therapy is a relatively safe and effective treatment for acute massive pulmonary embolism and should be considered as a first-line treatment option.”

CTD is performed in a hospital radiology suite by an interventional radiologist, who inserts a catheter into a vein in the leg (generally the popliteal vein) and threads it until it reaches the site of the blood clot. The image-guided catheter allows the doctor to watch the entire procedure on an X-ray video monitor. Once the tip of the catheter reaches the clot, a thrombolytic drug is infused into the clot through the catheter. In most cases, the blood clot will completely dissolve within a few days.

Related Links:

Stanford University Medical Center




Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Pulmonary Ventilator
OXYMAG
Critical Care Conversion Kit
Adapter+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.